Articles Archives - Page 513 of 766

WednesdayNov 18, 2020 11:34 am

Knightscope, Inc. Committed to Offering Peace Through Superior Technology with Autonomous Security Robots

Knightscope’s ASRs have completed over one million field hours and are continuing to improve over time based on field experience Knightscope designs, engineers, and builds its ASRs in Silicon Valley, continuing to create American jobs in an economy severely impacted by the pandemic The company is committed to changing the way public safety and protection are delivered nationwide By joining the $39 billion self-storage industry, Knightscope is targeting to become a prominent security provider in the sector, translating into further opportunities for growth Knightscope, a developer of advanced physical security technologies utilizing fully autonomous robots focused on enhancing U.S. security…

TuesdayNov 17, 2020 3:11 pm

Brain Scientific Inc. (BRSF) Offers Stock to Wider Pool of Investors Through Dalmore Group

BRSF announce partnership with Dalmore Group New product launch presents solution for growing need for rapid EEG testing due to COVID-19 pandemic Brain Scientific shose to extend proposed Reg A+ offering to attract additional investors Brain Scientific (BRSF), a commercial-stage healthcare company providing next-gen solutions to the neurology market, has announced a partnership with the Dalmore Group in a recent press release (https://ibn.fm/clcDx). "We are delighted to get the Dalmore Group on board and to be able to offer our stock to a much wider pool of investors,” said Brain Scientific chairman Boris Goldstein. “Our partners are experienced with Regulation…

TuesdayNov 17, 2020 2:53 pm

AzurRx BioPharma Inc. (NASDAQ: AZRX) Making Strides with MS1819 Clinical Trials for Cystic Fibrosis-Associated Pancreatic Insufficiency

Globally it is estimated that 70,000 people suffer from CF, with half the population in the United States The global CF therapeutics market size was valued at $4.62 billion in 2018 and is expected to reach an estimated $9.3 billion by 2026 AzurRx BioPharma’s MS1819, currently undergoing clinical trials, is a promising therapy for severe exocrine pancreatic insufficiency in patients with cystic fibrosis While still a relatively rare genetic disease, cystic fibrosis (“CF”) remains a dangerous condition that affects multiple body functions and organs, putting patients at risk of developing severe life-threatening illnesses. This is why the need for innovative…

TuesdayNov 17, 2020 2:31 pm

Josemaria Resources Inc. (TSX: JOSE) (OTC: JOSMF) Files Key Report, Notes Positive Study Regarding Argentine Property

Technical report supports recent positive feasibility study announcement Study projects average annual metal production of 136,000 tonnes of copper, 231,000 ounces of gold and million-plus ounces of silver Josemaria one of world’s very few readily developable copper-gold projects Josemaria Resources (TSX: JOSE) (OTC: JOSMF) has filed a key technical report to support its recent positive feasibility study announcement. The report, which was prepared under National Instrument 43-101 Standards for Disclosure for Mineral Projects, is in regard to the company’s wholly owned Josemaria Copper-Gold Project, located in San Juan Province in Argentina. Last month Josemaria Resources announced the positive results of…

TuesdayNov 17, 2020 11:20 am

QualityStocksNewsBreaks – Creatd Inc. (NASDAQ: CRTD) Announces Financial Numbers, Key Milestones for Third Quarter

Creatd (NASDAQ: CRTD), the parent company of Vocal, a proprietary technology platform for creators of all types, reported its financial numbers and outlined several business milestones achieved during its three-month and nine-month periods ending Sept. 30, 2020. Highlights of the report include Q3 revenues of $425,000, an increase of more than 32% compared to Q2 revenues of $323,000 and a fourfold increase over revenues of $91,000 for the same period last year. The company attributed the growth in revenues primarily to the increase of Vocal+ paid subscribers and the rising price points for Vocal for Brands' campaigns. Other highlights include the appointment of…

TuesdayNov 17, 2020 10:12 am

Pressure BioSciences’ (PBIO) First Issued U.S. Patent for Its Novel UST Platform Advances the Company Toward 2021 Product Delivery, Significant Acceleration of Revenue, and Profitability

Life sciences technology innovator Pressure BioSciences (OTCQB: PBIO) has increased its IP stable to 26 patents worldwide with the announcement of its first U.S. patent for its revolutionary Ultra Shear Technology(TM) (“UST”) Platform The patent (US 10,823,159) - entitled “System for High Pressure, High Shear Processing of Fluids” - will be the framework of the company’s new instrument line (the BaroShear K45 Nanoemulsification System) to be commercially released in mid-2021 UST is expected to revolutionize the processing of immiscible liquids into high quality, highly profitable nanoemulsions Nanoemulsions are highly sought after in a variety of industries because of their ability…

MondayNov 16, 2020 3:20 pm

HempFusion Wellness Builds Reputation for Safety in the Global CBD Market, Aims to IPO on TSX Exchange

HempFusion Wellness, Inc. is a health and wellness company developing the power of whole-food hemp nutrition through more than 40 products currently on store shelves The company is focused on industry safety and quality standards through regulatory compliance, and is currently participating in a real world consumer study to establish the safety of daily cannabidiol (“CBD”) use in regard to liver function HempFusion has filed a preliminary prospectus for a planned initial public offering of its stock in Canada and a listing on the Toronto Stock Exchange Despite a reduction in hemp farm acreage this year following last year’s glut,…

MondayNov 16, 2020 2:57 pm

Knightscope, Inc.’s AI-equipped Security Robots Building Confidence in Law Enforcement Sector

Knightscope is building a clientele for its robotic security force models, including about dozens of clients from Fortune 1000 companies, to law enforcement agencies, hospitals, casinos, water utilities, malls and manufacturing plants The company’s robots use artificial intelligence to navigate indoor and outdoor areas that are Americans with Disabilities Act compliant, and can be monitored with a simple browser and Internet connection The robots record data and use recognition features to assess potentially significant elements such as human activities, thermal changes and license plate information The privately held company is backed by more than 16,000 investors and four major corporations,…

MondayNov 16, 2020 12:26 pm

Predictive Oncology (NASDAQ: POAI) CEO Discusses Subsidiaries’ Proprietary Tech, Innovative Media

CEO expects results that will “build the stock and raise the stock price” POAI focused on positioning TumorGenesis kits to manufacturers Helomics has largest database of its kind in the world, brings cutting-edge technology to cancer research During a recent NetworkNewsWire exclusive audio interview, Predictive Oncology (NASDAQ: POAI) CEO Carl Schwartz noted recent company milestones and outlined strategic goals. In addition, Schwartz provided key updates on the company’s four impressive subsidiaries: Skyline Medical, TumorGenesis, Soluble Biotech and Helomics. “I’m very encouraged. I think we’re moving right along. Things never go as fast as we would like them, and it can be…

MondayNov 16, 2020 11:41 am

Utah Surplus Lines Insurance Licensing Opens Up New Markets and Opportunities for InsuraGuest Technologies, Inc. (TSX.V: ISGI) (OTC: IGSTF)

Subsidiary InsuraGuest Insurance Agency, LLC, is now licensed to offer surplus lines of casualty and property insurance in the state of Utah This licensing allows for more markets and additional products to be sold, which generates additional revenue and caters to InsuraGuest’s expansion goals in the insurance marketplace Company now offers its products and services throughout the United States in their entirety Surplus lines insurance market is expected to reach $125.9 billion by 2027 InsuraGuest Technologies (TSX.V: ISGI) (OTC: IGSTF), a leader in the insurtech industry, now offers its insurance services and products nationwide and has gained access to more…

Site Search

Company Search

Category: Articles